John C. Morris
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 57
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 13
- Immunology 42
- Immunotherapy and Immune Responses 23
- T-cell and Retrovirus Studies 13
- Immune Cell Function and Interaction 11
- Co-authors
- Jason C. SteelThomas A. WaldmannSulsal HaqueJohn E. JanikBrian J. MorrisonJay A. BerzofskyPing YuMeili Zhang
- Journals
- Journal of Clinical Oncology (26 papers)Blood (12 papers)Clinical Cancer Research (3 papers)Cancer Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
John C. Morris
114 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 121
- Immunology 1.5k
- Oncology 1.6k
- Otorhinolaryngology 82
- Cancer Research 272
- Pathology and Forensic Medicine 298
Countries citing papers authored by John C. Morris
This map shows the geographic impact of John C. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Morris more than expected).
Fields of papers citing papers by John C. Morris
This network shows the impact of papers produced by John C. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Morris. The network helps show where John C. Morris may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 2 | |
| 3 | 2020 | 19 | |
| 4 | 2019 | 1 | |
| 5 | 2019 | 12 | |
| 6 | 2018 | 12 | |
| 7 | 2017 | 3 | |
| 8 | 2017 | 95 | |
| 9 | 2016 | 3 | |
| 10 | 2015 | 117 | |
| 11 | 2013 | 129 | |
| 12 | 2012 | 50 | |
| 13 | 2011 | 131 | |
| 14 | 2011 | 278 | |
| 15 | 2010 | 172 | |
| 16 | 2010 | 16 | |
| 17 | 2008 | 38 | |
| 18 | 2005 | 70 | |
| 19 | 2004 | 77 | |
| 20 | 1997 | 35 |
About John C. Morris
John C. Morris is a scholar working on Oncology, Immunology, Biotechnology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 115 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), Cancer Immunotherapy and Biomarkers (17 papers), T-cell and Retrovirus Studies (13 papers), Lung Cancer Treatments and Mutations (13 papers), CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (11 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Cancer Research and Treatments (9 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.6k citations), Otorhinolaryngology (82 citations), Cancer Research (272 citations) and Pathology and Forensic Medicine (298 citations). John C. Morris has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Jason C. Steel, Thomas A. Waldmann, Sulsal Haque, John E. Janik, Brian J. Morrison, Jay A. Berzofsky, Ping Yu, Meili Zhang, Masaki Terabe and Deborah E. Citrin. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.